Clinical Trial Record

Return to Clinical Trials

Ultra Sound Guided Fine Needle Aspiration Cytology (FNAC) of Liver and Pancreas Tumours


2009-07


2011-09


2011-12


150

Study Overview

Ultra Sound Guided Fine Needle Aspiration Cytology (FNAC) of Liver and Pancreas Tumours

Patients with tumors in liver or pancreas are randomized to ultrasound (UL)-guided FNAC biopsies with guidance method or UL-guided FNAC biopsies with free-hand method.

N/A

  • Tumors in Liver
  • Tumors in Pancreas
  • PROCEDURE: FNAC (fine needle aspiration cytology)
  • H-KA-05092

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2009-10-07  

N/A  

2010-10-12  

2009-10-07  

N/A  

2010-10-13  

2009-10-08  

N/A  

2010-10  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Diagnostic


Allocation:
Randomized


Interventional Model:
Single Group


Masking:
Single


Arms and Interventions

Participant Group/ArmIntervention/Treatment
EXPERIMENTAL: biopsy arm

patients with tumors in liver and/or pancreas

PROCEDURE: FNAC (fine needle aspiration cytology)

  • UL guided biopsy
Primary Outcome MeasuresMeasure DescriptionTime Frame
quality of obtained biopsyone year
Secondary Outcome MeasuresMeasure DescriptionTime Frame
patients pain and discomfort at procedureimmediately

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • adult over 18 years
  • tumors in liver and/or pancreas

  • Exclusion Criteria:

  • low coagulation factors
  • mentally ill patients.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.


    • PRINCIPAL_INVESTIGATOR: Jakob Burcharth, MD, Herlev Hospital

    Publications

    The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

    General Publications

    No publications available